112 Participants Needed

HUSLS vs R-SCP for Pelvic Organ Prolapse

SS
CC
Overseen ByChristine Cota
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Loma Linda University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial compares two surgeries for treating pelvic organ prolapse: one uses a robot to place a supportive mesh, and the other uses stitches to lift and secure the organs through the vagina. The goal is to find out which method is more effective.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.

Is the treatment of pelvic organ prolapse using HUSLS or R-SCP generally safe for humans?

Research comparing robotic sacrocolpopexy (R-SCP) and uterosacral ligament suspension (USLS) for pelvic organ prolapse shows that both procedures have been evaluated for safety, with data on pain scores, opioid use, and adverse events. These studies suggest that both treatments are generally safe, with some differences in recovery experiences.12345

How does the treatment HUSLS vs R-SCP for pelvic organ prolapse differ from other treatments?

High uterosacral ligament suspension (HUSLS) and robotic sacrocolpopexy (R-SCP) are surgical treatments for pelvic organ prolapse, which occurs when pelvic organs drop from their normal position. HUSLS involves suspending the pelvic organs using the uterosacral ligaments, while R-SCP uses robotic assistance to attach the pelvic organs to the sacrum (a bone at the base of the spine). These methods are unique because they offer different surgical approaches to support the pelvic organs, with HUSLS being performed through the vagina and R-SCP using robotic technology for precision.14567

What data supports the effectiveness of the treatment High uterosacral ligament suspension and Robotic sacrocolpopexy for Pelvic Organ Prolapse?

Research shows that both high uterosacral ligament suspension and robotic sacrocolpopexy are effective in treating pelvic organ prolapse, with studies indicating positive long-term outcomes for these procedures in managing the condition.14567

Who Is on the Research Team?

SS

Sam Siddighi

Principal Investigator

Loma Linda University Health Care

Are You a Good Fit for This Trial?

This trial is for adults with symptomatic pelvic organ prolapse who can consent, attend all study visits, and have transportation within 2 hours of LLUH. It's not for those without transport or financial means, with Alzheimer's, dementia, opposition to mesh use due to beliefs or past complications, pregnancy plans during the study, chronic undetermined pelvic pain over 6 months, certain comorbidities like fibromyalgia or interstitial cystitis.

Inclusion Criteria

I feel a bulge or pressure in my pelvic area.
Signed Informed Consent
I can attend all required study visits.

Exclusion Criteria

I have had pelvic pain for over 6 months not related to my menstrual cycle and may also have fibromyalgia, interstitial cystitis, or vulvodynia.
I do not have dementia and can complete questionnaires.
You live more than 2 hours away from LLUH.
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either Robotic Sacrocolpopexy or High Uterosacral Ligament Suspension for pelvic organ prolapse repair

Surgical procedure

Follow-up

Participants are monitored for safety and effectiveness after treatment, including filling out questionnaires and POP-Q assessments

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • High uterosacral ligament suspension
  • Robotic sacrocolpopexy
Trial Overview The trial compares two surgical methods for fixing pelvic organ prolapse: Robotic Sacrocolpopexy (R-SCP) and High Uterosacral Ligament Suspension (HUSLS). The goal is to see which one works better in terms of effectiveness.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: SacrocolpopexyActive Control1 Intervention
Robotic sacrocolpopexy
Group II: HUSLSActive Control1 Intervention
Vaginal high uterosacral ligament suspension

Find a Clinic Near You

Who Is Running the Clinical Trial?

Loma Linda University

Lead Sponsor

Trials
322
Recruited
267,000+

Published Research Related to This Trial

In a study of 175 women who underwent either vaginal uterosacral ligament suspension (USLS) or minimally invasive sacrocolpopexy (SCP), both groups reported high satisfaction and low regret regarding their surgical decisions, indicating that both procedures are well-received.
However, women in the SCP group perceived slightly lower postoperative improvement compared to those in the USLS group, as indicated by their Patient Global Impression of Improvement (PGI-I) scores, suggesting that while both surgeries are effective, USLS may offer a better perceived outcome.
Satisfaction and Regret Following Uterosacral Ligament Suspension and Sacrocolpopexy: A Prospective Multicenter Analysis From the Fellows' Pelvic Research Network.Bastawros, D., Rabon, H., Noor, N., et al.[2021]

Citations

Uterosacral Ligament Suspension Versus Robotic Sacrocolpopexy for Treatment of Apical Pelvic Organ Prolapse. [2019]
[Long-term outcomes of the high vaginal uterosacral ligament suspension in treatment of the severe pelvic organ prolapse]. [2015]
Long-term outcomes of modified high uterosacral ligament vault suspension (HUSLS) at vaginal hysterectomy. [2021]
High uterosacral ligament vault suspension at vaginal hysterectomy: objective and subjective outcomes of a modified technique. [2015]
Midterm comparison of laparoscopic high uterosacral ligament suspension and sacrocolpopexy in the treatment of moderate to severe apical prolapse. [2023]
Perioperative outcomes after robotic versus vaginal surgery for pelvic organ prolapse. [2020]
Satisfaction and Regret Following Uterosacral Ligament Suspension and Sacrocolpopexy: A Prospective Multicenter Analysis From the Fellows' Pelvic Research Network. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security